254 related articles for article (PubMed ID: 9112674)
1. Molecular mechanisms of fibrin gel clot retraction by platelets and cultured tumor cells.
Tanoue K; Katagiri Y; Suzuki H
Pol J Pharmacol; 1996; 48(3):341-3. PubMed ID: 9112674
[TBL] [Abstract][Full Text] [Related]
2. Involvement of alpha v beta 3 integrin in mediating fibrin gel retraction.
Katagiri Y; Hiroyama T; Akamatsu N; Suzuki H; Yamazaki H; Tanoue K
J Biol Chem; 1995 Jan; 270(4):1785-90. PubMed ID: 7530248
[TBL] [Abstract][Full Text] [Related]
3. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa).
Podolnikova NP; Gorkun OV; Loreth RM; Yee VC; Lord ST; Ugarova TP
Biochemistry; 2005 Dec; 44(51):16920-30. PubMed ID: 16363805
[TBL] [Abstract][Full Text] [Related]
4. Serine/threonine phosphatases regulate platelet αIIbβ3 integrin receptor outside-in signaling mechanisms and clot retraction.
Moscardó A; Santos MT; Latorre A; Madrid I; Vallés J
Life Sci; 2013 Nov; 93(20):707-13. PubMed ID: 24096143
[TBL] [Abstract][Full Text] [Related]
5. Convulxin induces platelet activation by a tyrosine-kinase-dependent pathway and stimulates tyrosine phosphorylation of platelet proteins, including PLC gamma 2, independently of integrin alpha IIb beta 3.
Francischetti IM; Ghazaleh FA; Reis RA; Carlini CR; Guimarães JA
Arch Biochem Biophys; 1998 May; 353(2):239-50. PubMed ID: 9606958
[TBL] [Abstract][Full Text] [Related]
6. Beta 3 integrin-mediated fibrin clot retraction by nucleated cells: differing behavior of alpha IIb beta 3 and alpha v beta 3.
Chen YP; O'Toole TE; Leong L; Liu BQ; Diaz-Gonzalez F; Ginsberg MH
Blood; 1995 Oct; 86(7):2606-15. PubMed ID: 7545462
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein IIb/IIIa blockade inhibits platelet-mediated force development and reduces gel elastic modulus.
Carr ME; Carr SL; Hantgan RR; Braaten J
Thromb Haemost; 1995 Mar; 73(3):499-505. PubMed ID: 7667835
[TBL] [Abstract][Full Text] [Related]
8. [Variant of Paris-I Lariboisière thrombasthenia, a molecular anomaly of the IIb-IIIa platelet glycoprotein complex].
Caen JP; Rosa JP; Soria C; Boizard B
C R Seances Acad Sci III; 1983; 296(10):479-81. PubMed ID: 6223690
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the novel murine monoclonal anti-von Willebrand factor (vWf) antibody GUR76-23 which inhibits vWf interaction with alpha IIb beta 3 but not alpha v beta 3 integrin.
Yokoyama K; Handa M; Oda A; Katayama M; Fujimura Y; Murata M; Kawai Y; Watanabe K; Ikeda Y
Biochem Biophys Res Commun; 1997 May; 234(1):147-52. PubMed ID: 9168979
[TBL] [Abstract][Full Text] [Related]
10. Fibrin clot retraction by human platelets correlates with alpha(IIb)beta(3) integrin-dependent protein tyrosine dephosphorylation.
Osdoit S; Rosa JP
J Biol Chem; 2001 Mar; 276(9):6703-10. PubMed ID: 11084040
[TBL] [Abstract][Full Text] [Related]
11. Factor H binds to platelet integrin alphaIIbbeta3.
Mnjoyan Z; Li J; Afshar-Kharghan V
Platelets; 2008 Nov; 19(7):512-9. PubMed ID: 18979363
[TBL] [Abstract][Full Text] [Related]
12. Active GPIIb-IIIa conformations that link ligand interaction with cytoskeletal reorganization.
Mondoro TH; White MM; Jennings LK
Blood; 2000 Oct; 96(7):2487-95. PubMed ID: 11001901
[TBL] [Abstract][Full Text] [Related]
13. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
14. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel binding site for platelet integrins alpha IIb beta 3 (GPIIbIIIa) and alpha 5 beta 1 in the gamma C-domain of fibrinogen.
Podolnikova NP; Yakubenko VP; Volkov GL; Plow EF; Ugarova TP
J Biol Chem; 2003 Aug; 278(34):32251-8. PubMed ID: 12799374
[TBL] [Abstract][Full Text] [Related]
16. Anti-human platelet tetraspanin (CD9) monoclonal antibodies induce platelet integrin alpha IIb beta 3 activation in a Fc receptor-independent fashion.
Wu H; Li J; Peng L; Liu H; Wu W; Zhou Y; Hou Q; Kong D
Chin Med J (Engl); 2001 Jan; 114(1):14-8. PubMed ID: 11779428
[TBL] [Abstract][Full Text] [Related]
17. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
18. Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets.
Prévost N; Woulfe DS; Jiang H; Stalker TJ; Marchese P; Ruggeri ZM; Brass LF
Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9820-5. PubMed ID: 15994237
[TBL] [Abstract][Full Text] [Related]
19. Reassociation and translocation of glycoprotein IIB-IIIA in EDTA-treated human platelets.
Ma Y; Wong K
Platelets; 2007 Sep; 18(6):451-9. PubMed ID: 17763154
[TBL] [Abstract][Full Text] [Related]
20. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
Liu CZ; Shih MH; Tsai PJ
Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]